S'abonner

Symptom Profiles Differ in Patients With Neuropathic Versus Non-neuropathic Pain - 11/08/11

Doi : 10.1016/j.jpain.2006.06.005 
Robert H. Dworkin , Mark P. Jensen , Arnold R. Gammaitoni , David O. Olaleye §, Bradley S. Galer
 Departments of Anesthesiology and Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York. 
 Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle, Washington. 
 Endo Pharmaceuticals, Chadds Ford, Pennsylvania. 
§ SAS Institute, Cary, North Carolina. 
 Topiceutical, West Chester, Pennsylvania. 

Address reprint requests to Robert H. Dworkin, PhD, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 604, Rochester, NY, 14642.

Abstract

The distinction between neuropathic and non-neuropathic pain reflects partially distinct mechanisms and patterns of treatment response. It was therefore hypothesized that patients with neuropathic and non-neuropathic pain have different profiles of symptoms and signs. To test this hypothesis, pain intensity, unpleasantness, quality, and spatial characteristics were examined in 618 patients with 1 of 3 peripheral neuropathic pain conditions (painful diabetic peripheral neuropathy, painful idiopathic sensory polyneuropathy, or postherpetic neuralgia), osteoarthritis pain, or low back pain. These assessments were conducted before treatment had begun in clinical trials of lidocaine patch 5% administered alone or with stable dosages of other analgesics. Patients with osteoarthritis pain and low back pain did not differ in their profile of pain quality and spatial characteristics and were combined to form a group of patients with non-neuropathic pain. In univariate analyses, patients with peripheral neuropathic pain reported significantly more intense hot, cold, sensitive, itchy, and surface pain and significantly less intense dull and deep pain than patients with non-neuropathic pain. In a multivariate analysis, the overall pattern of pain quality and spatial characteristics differed significantly between patients with neuropathic and non-neuropathic pain. In addition, specific pain quality and spatial characteristics improved the discrimination of patients with neuropathic and non-neuropathic pain in a logistic regression model that adjusted for demographic covariates and overall pain intensity and unpleasantness.

Perspective

The results indicate that the distinction between neuropathic and non-neuropathic pain is reflected in different profiles of pain quality and spatial characteristics and suggest that the assessment of patterns of pain symptoms might contribute to the identification of distinct pathophysiologic mechanisms and the development of mechanism-based treatment approaches.

Le texte complet de cet article est disponible en PDF.

Key words : Neuropathic pain, symptoms, pain quality, non-neuropathic pain, low back pain, osteoarthritis pain


Plan


 Supported by a grant from Endo Pharmaceuticals to the University of Rochester Office of Professional Education. RHD has received research support, consulting fees, or honoraria in the past year from Allergan, Astellas Pharma, Biomedical Development Corporation, Cephalon, Dov Pharmaceuticals, Eli Lilly & Co, Endo Pharmaceuticals, EpiCept Corporation, Fralex Therapeutics, NeurogesX (also stock options), Novartis Pharmaceuticals, Organon, Pfizer, UCB Pharma, US Food and Drug Administration, US National Institutes of Health, Wyeth, and Yamanouchi Europe. MPJ has received research support or consulting fees in the past year from Depomed, Endo Pharmaceuticals, Fralex Therapeutics (also stock options), and Pfizer. ARG is an employee of and holds stock options in Endo Pharmaceuticals.


© 2007  American Pain Society. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 8 - N° 2

P. 118-126 - février 2007 Retour au numéro
Article précédent Article précédent
  • Peripheral Formalin Injection Induces Long-Lasting Increases in Cyclooxygenase 1 Expression by Microglia in the Spinal Cord
  • Fei-Yu Zhang, You Wan, Zhen-Kang Zhang, Alan R. Light, Kai-Yuan Fu
| Article suivant Article suivant
  • Cytokine Profiles During Carrageenan-Induced Inflammatory Hyperalgesia in Rat Muscle and Hind Paw
  • L.C. Loram, A. Fuller, L.G. Fick, T. Cartmell, S. Poole, D. Mitchell

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.